Marit G. A. van Vonderen

Author

Also Known As

A S Bosma, A. Stegeman, Astrid M L Oude Lashof, Heidi S M Amerlaan, Heidi S.M. Amerlaan, M G A van Vonderen, M. G. A. van Vonderen, M. Stevens, M.G.A. van Vonderen, Marit G A van Vonderen

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

University of Amsterdam Medisch Centrum Leeuwarden Amsterdam University Medical Centers Amsterdam UMC Location University of Amsterdam Amsterdam UMC Location Vrije Universiteit Amsterdam

About

Marit G. A. van Vonderen is an author at University of Amsterdam specializing in medicine, hiv, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	250
2	Cell Biology	1	1	61
3	Cellular Therapies	1	1	61
4	Emergency Medicine	1	1	31
5	Epidemiology	1	1	72

Marit G. A. van Vonderen

Publications

514

Citations

H-Index

Page 1

	Year	Citations
Carotid Intima-Media Thickness and Arterial Stiffness in HIV-Infected Patients: The Role of HIV, Antiretroviral Therapy, and Lipodystrophy Marit G. A. van Vonderen, Yvo M. Smulders, Coen D.A. Stehouwer, JAIDS Journal of Acquired Immune Deficiency Syndromes	2009	97
Increase in Carotid Artery Intima‐Media Thickness and Arterial Stiffness but Improvement in Several Markers of Endothelial Function after Initiation of Antiretroviral Therapy Marit G. A. van Vonderen, Elly A. Hassink, Michiel A. van Agtmael, The Journal of Infectious Diseases Vascular DiseaseCombination Antiretroviral TherapyImmunologyEndothelial FunctionPharmacotherapy	2009	86
HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals: a retrospective cohort study Colette Smit, Anders Boyd, Bart Rijnders, The Lancet HIV Retrospective Cohort StudyTreatment And PreventionHuman RetrovirusHcv Micro-eliminationAntiviral Therapy	2020	72
Cutting Edge: Rapid Recovery of NKT Cells upon Institution of Highly Active Antiretroviral Therapy for HIV-1 Infection Hans van Vliet, Marit G. A. van Vonderen, Johan W. Molling, The Journal of Immunology Cell TherapyCd4+ Nkt CellsT-regulatory CellImmunologyCd4 T Cell Responses	2006	61
Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study Kathryn S. Hensley, Marlou J. Jongkees, Daryl Geers, PLoS Medicine	2022	42
Ribavirin in the treatment of severe acute respiratory syndrome (SARS). Marit G. A. van Vonderen, Jeannet C. Bos, Jan M. Prins, PubMed Acute Lung InjuryRespiratory Distress Syndrome (Pulmonary Critical Care)Respiratory DiseasesAcute CareRespiratory Infection	2003	31
Insulin Sensitivity in Multiple Pathways Is Differently Affected During Zidovudine/Lamivudine-Containing Compared With NRTI-Sparing Combination Antiretroviral Therapy Marit G. A. van Vonderen, Regje M. E. Blümer, Elly A. Hassink, JAIDS Journal of Acquired Immune Deficiency Syndromes	2010	25
Timely administration of tocilizumab improves outcome of hospitalized COVID-19 patients Abraham Rutgers, Peter E. Westerweel, Bronno van der Holt, PLoS ONE	2022	21
Immunogenicity of an Additional mRNA-1273 SARS-CoV-2 Vaccination in People With HIV With Hyporesponse After Primary Vaccination Marlou J. Jongkees, Daryl Geers, Kathryn S. Hensley, The Journal of Infectious Diseases	2022	19
Zidovudine/lamivudine but not nevirapine in combination with lopinavir/ritonavir decreases subcutaneous adipose tissue mitochondrial DNA Eoin R. Feeney, Marit G. A. van Vonderen, Ferdinand W.N.M. Wit, AIDS	2012	18

Page 1